PPTA · Perpetua Resources Corp. · Stock research

Current Thesis

The narrative leg on offer is a funded domestic critical-minerals developer: the only identified US antimony reserve, with a $2.9 billion senior secured EXIM loan unanimously approved by the bank's board on 2026-05-21 under the Make More in America Initiative, construction restarted after a federal court denied activist groups' preliminary-injunction request on 2026-05-29, and — new since late July — a second and third metal in the story (antimony trisulfide for munitions, tungsten). What an investor is buying is the gap between a $3.15 billion market capitalisation (125.10 million shares, stockanalysis.com, 2026-08-16) and a project that does not target initial production until late 2029.

Life-cycle label: ACCELERATING, dated by three items in a nineteen-day window — the 2026-07-30 opening of a modular antimony-trisulfide pilot plant with the U.S. Army and Idaho National Laboratory in Idaho Falls, the 2026-08-06 exploration release (21.3 m @ 3.2 g/t gold and 0.9% tungsten at the Clark Tunnel Fault Zone, plus a new gold-tungsten zone), and the 7.75% single-session advance on 2026-08-07 that followed it. The qualifier matters: the financing narrative peaked and matured after the May EXIM approval — the stock closed 2026-08-14 at $25.24, 32.2% below its $37.22 52-week high, with a three-month return of −10.4%. This is a second leg building off a drawdown, not a fresh discovery of the name.

Bullish and bearish views on Perpetua Resources Corp.

The model's bull view on Perpetua Resources Corp. (PPTA), in brief: Balance sheet carries the interim. Cash of approximately $669.5 million at 2026-03-31 funded the H1 2026 engineering, site works and long-lead programme while full project financing is documented (Q1 2026 release, 2026-05-11). The permitting/litigation overhang thinned. After… The bear view: The commodity underwriting the strategic premium is falling. Both cases follow in full.

Bull Case

• Balance sheet carries the interim. Cash of approximately $669.5 million at 2026-03-31 funded the H1 2026 engineering, site works and long-lead programme while full project financing is documented (Q1 2026 release, 2026-05-11).
• The permitting/litigation overhang thinned. After the 2026-05-29 injunction denial, the company commenced additional 2026 field-season construction including Burntlog Route infrastructure.
• Defence pull-through is now physical. The 2026-07-30 Idaho Falls pilot plant with the U.S. Army and INL is the demonstration step in a "ground-to-round" antimony-trisulfide chain, not a memorandum.
• A third metal appeared for free. The 2026-08-06 release added a gold-tungsten zone and 0.9% tungsten in the CTFZ intercept; the company cites Chinese export restrictions lifting APT prices over 500%. Roughly 10,000 m of core drilling is planned in 2026 across four rigs.
• Sell-side sits above spot. H.C. Wainwright carries a $41 target with a Buy; B. Riley maintains Buy at $30 (target cut from $40, reported 2026-07-31/2026-08-03); stockanalysis.com shows a $36.90 consensus target as of 2026-08-16 — all above the 2026-08-14 close of $25.24.

Bear Case

• The commodity underwriting the strategic premium is falling. Antimony was quoted at $51.80/kg on 2026-08-14, −5.85% year-to-date and −21.70% since the start of 2025 (strategicmetalsinvest.com). The scarcity story and the price series have diverged.
• De-escalation is live. China's MOFCOM suspended its export ban on antimony and related dual-use items destined for the US, with the suspension running to 2026-11-27. The 2024 sequence — August 2024 export controls, September 2024 licensing, December 2024 outright US ban — is what created the re-rating; its unwind works the other way.
• No revenue, real burn. Q1 2026 net loss was $48.6 million, EPS −$0.39 (10-Q). Initial production is targeted for late 2029; every quarter until then is cash out.
• The loan is approved but not documented. Documentation is expected in the second half of 2026; drawdown conditions are unmet until it closes, and the rate is fixed against the long-dated Treasury at first drawdown, so a back-up in long yields raises the interest bill directly.
• Capex creep is already visible. The Hatch EPCM contract was amended to add pressure-oxidation and oxygen system design and installation at a revised control budget of $204.3 million.
• A price target came down while the stock rallied. B. Riley cut to $30 from $40 on 2026-07-31 — a −25% target reduction from a firm still rated Buy, three weeks before the stock's RSI reached 80.4.

Setup & Price Structure

Reference close 2026-08-14: $25.24. 52-week high $37.22 (−32.2%). Three-month return −10.4%. RSI(14) 80.4.

That combination is the whole structure: a violently overbought oscillator on a chart that is still a third below its high. Price fell through May–July, then recovered hard on the pilot-plant and drill headlines. Nothing here has reclaimed the post-EXIM May highs, so the August advance is a retracement inside a broken uptrend until it proves otherwise.

Crowding and positioning observables, stated as observables:

• RSI(14) at 80.4 on 2026-08-14 — the top decile of readings for most equities, reached without a new high.
• A +7.75% single session on 2026-08-07 on an exploration release, i.e. the marginal bid is responding to drill assays rather than to financing progress.
• Every published target found is above spot: $30 (B. Riley), $41 (H.C. Wainwright), $36.90 consensus — with the most recent revision being downward.
• A quarterly disclosure lands inside the week: stockanalysis.com's feed shows the Q2 2026 report published 2026-08-14 while the same source still lists 2026-08-19 as the next scheduled earnings date. Treat the exact date as unconfirmed and the event as imminent either way.
• Development-stage issuers with an undocumented project loan and a −$48.6m quarter are structurally capable of equity issuance into strength; no 2026 insider-transaction or issuance data was located for this note, and none is asserted.

Chasing an 80-RSI extension into an unconfirmed print, 32% below the high, is the least favourable entry geometry this name offers. A pullback that holds above the July base while the tungsten and financing threads develop is the more legible structure.

Catalyst Calendar (next 30 days)

• ~2026-08-19 (est., unconfirmed) — Q2 2026 results / 10-Q. Cash on hand versus the $669.5m at 2026-03-31, construction spend rate, and management's language on EXIM documentation timing.
• H2 2026, no fixed date (could land inside the window) — EXIM loan documentation and first drawdown conditions; the rate fixes against the long-dated Treasury plus 100 bps at first drawdown.
• 2026-11-27 (outside 30 days, but the clock is visible now) — expiry of China's suspension of the antimony export ban to the US.

Elapsed catalysts

• ~2026-09 (est.) — further assay releases from the ~10,000 m, four-rig 2026 drill programme; the 2026-08-06 batch is explicitly not the last. (passed 11d ago)

What Would Change Our Mind

The structural break is the August advance round-tripping: a weekly close below $21 would give back the entire discovery-driven leg — roughly 17% under the 2026-08-14 close of $25.24 — and put the name back in the range that produced a 25% sell-side target cut on 2026-07-31, with the RSI-80 impulse of mid-August confirmed as a failed rally rather than the start of a second leg.

Secondary conditions that would independently break the read:

• The quarterly print comes and goes without an EXIM documentation timeline. If the Q2 disclosure carries no date-bearing progress on closing the $2.9bn facility, the financing catalyst has slipped from H2 2026 and the funded-developer framing weakens.
• Antimony continues to bleed. A move materially below the $51.80/kg quoted on 2026-08-14, especially if China's suspension is made permanent before 2026-11-27, removes the scarcity premium embedded in a $3.15bn valuation on a 2029 producer.
• Equity issuance into this strength. A marketed offering priced off an RSI-80 tape would signal the EXIM facility does not cover the full capital requirement.
• Theme flips to SATURATED. If critical-minerals coverage broadens to mainstream generalist outlets while the drill releases stop moving the price more than a session, the fresh-attention leg is spent.

Correlation Notes

• US–China trade escalation headlines are the dominant exogenous driver; the name re-rated on the 2024-08-14 export controls and the December 2024 US ban, and the 2026-11-27 suspension expiry is the next scheduled binary in that channel.
• Gold. Stibnite is a gold project with antimony credits; the bulk of the resource value tracks bullion, so PPTA trades with the developer complex and gold-miner beta, amplified by pre-production leverage.
• Antimony and tungsten (APT) spot set the strategic-premium multiple, not near-term cash flow — there is none before late 2029.

• The domestic critical-minerals basket (rare-earth and defence-supply-chain names benefiting from DPA/EXIM-style federal capital) tends to move together on policy headlines; PPTA's differentiator inside that basket is that its federal financing is already board-approved rather than proposed.